[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Response to EDL at PHC
- From: "DR.J.S. BAPNA" <wasp_congress@vsnl.com>
- Date: Thu, 9 May 2002 02:35:27 -0400 (EDT)
Response to EDL at PHC
-----------------------
Dear Dr. Sudarshan,
I read with interest your response to EDL at PHC. I agree with you
that it is important to establish guidelines for the EDL.
Perhaps the best entry will be through the STGs guidelines. The
criteria for selection of drugs are documented in WHO's ?Technical
Report -Use of Essential Drugs' which is now called 'Essential
Medicines'.
With best wishes,
Yours sincerely,
J.S. Bapna
(The hyperlink to the useful information provided by Dr. Bapna is on
the WHO website:
http://www.who.int/medicines/organization/par/edl/trs/trs895.shtml
provides info regarding
Technical Report Series 895: The Use of Essential Drugs, 9th Report of
the WHO Expert Committee (2000)
http://www.who.int/medicines/organization/par/edl/procedures.shtml
provides info regarding Procedure to update and disseminate the WHO
Model List of Essential Medicines.----------Sunitha)
________________________________________________________________________
For live cricket scores download Yahoo! Score Tracker
at: http://in.sports.yahoo.com/cricket/tracker.html
The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.
To send a message to india-drug, write to: india-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@usa.healthnet.org
|